SEARCH OUR PRODUCT CATALOG

ORAOV1-CCND1 Fusion FISH Probe

The ORAOV1-CCND1 Fusion FISH Probe is used to confirm a fusion of the ORAOV1 and CCND1 genes. The fusion of the ORAOV1 and CCND1 genes has been associated with Head And Neck Squamous Cell Carcinoma . These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.

** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.

Turnaround Time: 7-10 Business Days    Shipping Time: 1-2 Day Expedited Shipping

SKU Test Kits Buffer Dye Color Order Now
ORAOV1-CCND1-20-ORGR  (Standard Design) 20 (40 μL) 200 μL
ORAOV1-CCND1-20-RERE 20 (40 μL) 200 μL
ORAOV1-CCND1-20-REOR 20 (40 μL) 200 μL
ORAOV1-CCND1-20-REGO 20 (40 μL) 200 μL
ORAOV1-CCND1-20-REGR 20 (40 μL) 200 μL
ORAOV1-CCND1-20-REAQ 20 (40 μL) 200 μL
ORAOV1-CCND1-20-ORRE 20 (40 μL) 200 μL
ORAOV1-CCND1-20-OROR 20 (40 μL) 200 μL
ORAOV1-CCND1-20-ORGO 20 (40 μL) 200 μL
ORAOV1-CCND1-20-ORAQ 20 (40 μL) 200 μL
ORAOV1-CCND1-20-GORE 20 (40 μL) 200 μL
ORAOV1-CCND1-20-GOOR 20 (40 μL) 200 μL
ORAOV1-CCND1-20-GOGO 20 (40 μL) 200 μL
ORAOV1-CCND1-20-GOGR 20 (40 μL) 200 μL
ORAOV1-CCND1-20-GOAQ 20 (40 μL) 200 μL
ORAOV1-CCND1-20-GRRE 20 (40 μL) 200 μL
ORAOV1-CCND1-20-GROR 20 (40 μL) 200 μL
ORAOV1-CCND1-20-GRGO 20 (40 μL) 200 μL
ORAOV1-CCND1-20-GRGR 20 (40 μL) 200 μL
ORAOV1-CCND1-20-GRAQ 20 (40 μL) 200 μL
ORAOV1-CCND1-20-AQRE 20 (40 μL) 200 μL
ORAOV1-CCND1-20-AQOR 20 (40 μL) 200 μL
ORAOV1-CCND1-20-AQGO 20 (40 μL) 200 μL
ORAOV1-CCND1-20-AQGR 20 (40 μL) 200 μL
ORAOV1-CCND1-20-AQAQ 20 (40 μL) 200 μL

CCND1 Gene Summary

The protein encoded by this gene belongs to the highly conserved cyclin family, whose members are characterized by a dramatic periodicity in protein abundance throughout the cell cycle. Cyclins function as regulators of CDK kinases. Different cyclins exhibit distinct expression and degradation patterns which contribute to the temporal coordination of each mitotic event. This cyclin forms a complex with and functions as a regulatory subunit of CDK4 or CDK6, whose activity is required for cell cycle G1/S transition. This protein has been shown to interact with tumor suppressor protein Rb and the expression of this gene is regulated positively by Rb. Mutations, amplification and overexpression of this gene, which alters cell cycle progression, are observed frequently in a variety of tumors and may contribute to tumorigenesis. [provided by RefSeq, Jul 2008]

Gene Name: Cyclin D1

Chromosome: CHR11: 69455872 -69469242

Locus: 11q13.3

ORAOV1 Gene Summary

The Oral Cancer Overexpressed 1 (ORAOV1) gene is located on chr11 :69480331-69490165 at 11q13.3.

Gene Name: Oral Cancer Overexpressed 1

Chromosome: CHR11: 69480331 -69490165

Locus: 11q13.3

Gene Diseases

The ORAOV1 CCND1 Fusion has been associated with the following diseases:

Disease Name
Head And Neck Squamous Cell Carcinoma 

FISH Probe Protocols

Protocol, Procedure, or Form Name Last Modified Download

Distinct Patterns of Acral Melanoma Based on Site and Relative Sun Exposure

Acral melanomas vary considerably in their molecular, histological, and clinical presentation. In this study, acral melanomas from dorsal, volar, and subungual-interdigital body sites were assessed using several tests, including FISH. Our TERT, CCND1, CDK4, AURKA, CDKN2A, PAK1, PTEN, NF1, and GAB2 probes were used to detect copy number variations in these genes. Genetic profiles were found to be tightly tied to UV exposure.

Distinct Patterns of Acral Melanoma Based on Site and Relative Sun Exposure

Acral melanomas vary considerably in their molecular, histological, and clinical presentation. In this study, acral melanomas from dorsal, volar, and subungual-interdigital body sites were assessed using several tests, including FISH. Our TERT, CCND1, CDK4, AURKA, CDKN2A, PAK1, PTEN, NF1, and GAB2 probes were used to detect copy number variations in these genes. Genetic profiles were found to be tightly tied to UV exposure.

LobSig is a multigene predictor of outcome in invasive lobular carcinoma

Invasive lobular carcinoma (ILC) is a type of breast cancer defined by functional loss of E-cadherin, which results in cellular adhesion defects. This study sought to further characterize ILC’s genetic profile via analysis of 196 tumors. Using in silico integrative analyses, a 194-gene set – named ‘LobSig’ by the team – was identified, made up of genes frequently mutated in the tumor samples. LobSig was tested against the Nottingham Prognostic Index, PAM50 risk-of-recurrence (Prosigna), OncotypeDx, and Genomic Grade Index (MapQuantDx) for a 10-year follow-up period, and outperformed them all. As part of genetic profiling, Empire Genomics’ FGFR1 And CCND1 FISH probes were used to detect amplification of the genes.